论文部分内容阅读
目的分析干扰素栓联合阿奇霉素治疗于衣原体、支原体性宫颈炎的临床疗效。方法将2016年3月-2017年3月在我院接受治疗的衣原体、支原体性宫颈炎患者100例,应用投掷硬币的方式将其分为观察组与对照组每组50例,给予对照组患者实施单独干扰素治疗,给予观察组患者在对照组患者的基础上联合阿奇霉素治疗,对比2组患者治疗后的临床疗效及转阴率情况。结果观察组患者在治疗后的总有效率为96%明显高于对照组66%,治疗后的转阴率为90%明显高于对照组的62%,治疗后3个月的复发率为2%低于对照组的30%,差异有统计学意义(P<0.05)。结论衣原体、支原体性宫颈炎患者应用联合干扰素栓联合阿奇霉素治疗可显著提高有效率及转阴率,降低复发率,有较高的临床应用价值。
Objective To analyze the clinical efficacy of interferon suppository combined with azithromycin in the treatment of chlamydia and mycoplasma cervicitis. Methods 100 cases of chlamydia and mycoplasma cervicitis who were treated in our hospital from March 2016 to March 2017 were divided into observation group and control group by coin throwing method and 50 cases in each group were given control group Interferon treatment alone, the observation group of patients in the control group based on the combination of azithromycin treatment, compared two groups of patients after treatment of clinical efficacy and negative conversion rate. Results The total effective rate of the observation group after treatment was 96%, which was significantly higher than that of the control group (66%). After treatment, the negative conversion rate (90%) was significantly higher than that of the control group (62%), and the recurrence rate was 3 % Lower than 30% of the control group, the difference was statistically significant (P <0.05). Conclusion Chlamydia, mycoplasma cervicitis patients combined with interferon suppository combined with azithromycin can significantly improve the efficiency and negative conversion rate, reduce the recurrence rate, and has a high clinical value.